% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Doege:143008,
author = {D. Doege$^*$ and M. Thong$^*$ and L. Koch-Gallenkamp$^*$
and H. Bertram and A. Eberle and B. Holleczek and R.
Pritzkuleit and M. Waldeyer-Sauerland and A. Waldmann and S.
R. Zeissig and L. Jansen$^*$ and H. Brenner$^*$ and V.
Arndt$^*$},
title = {{H}ealth-related quality of life in long-term disease-free
breast cancer survivors versus female population controls in
{G}ermany.},
journal = {Breast cancer research and treatment},
volume = {175},
number = {2},
issn = {1573-7217},
address = {Dordrecht [u.a.]},
publisher = {Springer Science + Business Media B.V.},
reportid = {DKFZ-2019-00633},
pages = {499-510},
year = {2019},
abstract = {Little is known about breast cancer (BC) survivors'
health-related quality of life (HRQoL) > 5 or even
> 10 years past diagnosis. It is of interest whether, in
the long run, survivors' HRQoL aligns with that of the
general population. Study objectives were to (1) compare
disease-free BC survivors' HRQoL to that of non-cancer
controls, and (2) compare long-term survivors (LTS,
5-9 years post-diagnosis), very long-term survivors (VLTS,
≥ 10 years post-diagnosis), and controls with respect
to their HRQoL.The samples of 2647 disease-free BC survivors
(5-16 years post-diagnosis) and 1005 population controls
were recruited in German multi-regional population-based
studies. HRQoL was assessed by the European Organization for
Research and Treatment of Cancer Quality of Life
Questionnaire-Core 30 (EORTC QLQ-C30). Differences in HRQoL
were assessed with multiple regression, controlling for age
and education.Disease-free BC survivors < 80 years (at
survey) reported overall global health status/quality of
life comparable to controls, but statistically significant
lower physical, role, emotional, social, and cognitive
functioning. They also indicated more fatigue, insomnia,
dyspnoea, and financial difficulties. However, differences
were only of trivial or small clinical relevance. At age
80-89, no differences between BC survivors and controls were
observed. Deficits in emotional and cognitive functioning
and some symptoms (e.g. insomnia and fatigue) persist, as
both LTS and VLTS reported more detriments than controls.In
view of the persistent, small but significant detriments in
disease-free BC survivors' cognitive and emotional
functioning and higher symptom burden, possibilities to
prevent detriments from becoming chronic should be
explored.},
cin = {C071 / C070 / C120},
ddc = {610},
cid = {I:(DE-He78)C071-20160331 / I:(DE-He78)C070-20160331 /
I:(DE-He78)C120-20160331},
pnm = {313 - Cancer risk factors and prevention (POF3-313)},
pid = {G:(DE-HGF)POF3-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:30826935},
doi = {10.1007/s10549-019-05188-x},
url = {https://inrepo02.dkfz.de/record/143008},
}